110 related articles for article (PubMed ID: 30378780)
1. Standardization of Growth Hormone and Insulin-like Growth Factor-I Measurement.
Katsumata N
Pediatr Endocrinol Rev; 2018 Sep; 16(Suppl 1):28-32. PubMed ID: 30378780
[TBL] [Abstract][Full Text] [Related]
2. Standardization of Growth Hormone and Insulin-like Growth Factor-I Measurements.
Katsumata N
Pediatr Endocrinol Rev; 2017 Mar; 14 Suppl 1(Suppl 1):209-215. PubMed ID: 28516748
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone (GH) secretory dynamics in a case of acromegalic gigantism associated with hyperprolactinemia: nonpulsatile secretion of GH may induce elevated insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 levels.
Yoshida T; Shimatsu A; Sakane N; Hizuka N; Horikawa R; Tanaka T
J Clin Endocrinol Metab; 1996 Jan; 81(1):310-3. PubMed ID: 8550769
[TBL] [Abstract][Full Text] [Related]
4. The measurement of insulin-like growth factor I: clinical applications and significance.
Teale JD; Marks V
Ann Clin Biochem; 1986 Jul; 23 ( Pt 4)():413-24. PubMed ID: 3094423
[TBL] [Abstract][Full Text] [Related]
5. Serum IGF-I measured by four different immunoassays in patients with adult GH deficiency or acromegaly and in a control population.
Granada ML; Ulied A; Casanueva FF; Pico A; Lucas T; Torres E; Sanmartí A
Clin Endocrinol (Oxf); 2008 Jun; 68(6):942-50. PubMed ID: 17980002
[TBL] [Abstract][Full Text] [Related]
6. Body mass index and insulin-like growth factor 1 as risk factors for discordant growth hormone and insulin-like growth factor 1 levels following pituitary surgery in acromegaly.
Zhang S; Li Y; Guo X; Gao L; Lian W; Yao Y; Feng M; Bao X; Wang R; Xing B
J Formos Med Assoc; 2018 Jan; 117(1):34-41. PubMed ID: 28341329
[TBL] [Abstract][Full Text] [Related]
7. Cardiac and metabolic effects of chronic growth hormone and insulin-like growth factor I excess in young adults with pituitary gigantism.
Bondanelli M; Bonadonna S; Ambrosio MR; Doga M; Gola M; Onofri A; Zatelli MC; Giustina A; degli Uberti EC
Metabolism; 2005 Sep; 54(9):1174-80. PubMed ID: 16125529
[TBL] [Abstract][Full Text] [Related]
8. Continuing efforts to standardize measured serum growth hormone values in Japan.
Katsumata N; Shimatsu A; Tachibana K; Hizuka N; Horikawa R; Yokoya S; Tatsumi KI; Mochizuki T; Anzo M; Tanaka T
Endocr J; 2016 Oct; 63(10):933-936. PubMed ID: 27452373
[TBL] [Abstract][Full Text] [Related]
9. Acromegalic gigantism with low serum level of growth hormone and elevated serum insulin-like growth factor-I.
Miyazaki R; Yoshida T; Sakane N; Yasuda T; Umekawa T; Kondo M; Shimatsu A; Hizuka N; Sano T
Intern Med; 1995 Mar; 34(3):183-7. PubMed ID: 7787324
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly.
Freda PU; Post KD; Powell JS; Wardlaw SL
J Clin Endocrinol Metab; 1998 Nov; 83(11):3808-16. PubMed ID: 9814451
[TBL] [Abstract][Full Text] [Related]
11. How are growth hormone and insulin-like growth factor-1 reported as markers for drug effectiveness in clinical acromegaly research? A comprehensive methodologic review.
van Esdonk MJ; van Zutphen EJM; Roelfsema F; Pereira AM; van der Graaf PH; Biermasz NR; Stevens J; Burggraaf J
Pituitary; 2018 Jun; 21(3):310-322. PubMed ID: 29605877
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults.
Marzullo P; Di Somma C; Pratt KL; Khosravi J; Diamandis A; Lombardi G; Colao A; Rosenfeld RG
J Clin Endocrinol Metab; 2001 Jul; 86(7):3001-8. PubMed ID: 11443159
[TBL] [Abstract][Full Text] [Related]
13. [Recent progress in the diagnosis of growth hormone (GH) disorders].
Shimatsu A
Rinsho Byori; 1997 Sep; 45(9):837-43. PubMed ID: 9311256
[TBL] [Abstract][Full Text] [Related]
14. Klotho and the Growth Hormone/Insulin-Like Growth Factor 1 Axis: Novel Insights into Complex Interactions.
Rubinek T; Modan-Moses D
Vitam Horm; 2016; 101():85-118. PubMed ID: 27125739
[TBL] [Abstract][Full Text] [Related]
15. Acromegaly and serum insulin-like growth factor I.
Thorner MO
Horm Res; 2004; 62 Suppl 1():34-6. PubMed ID: 15761230
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of serum IGF-I and IGFBP-3 in growth hormone disorders in adults.
Kim HJ; Kwon SH; Kim SW; Park DJ; Shin CS; Park KS; Kim SY; Cho BY; Lee HK
Horm Res; 2001; 56(3-4):117-23. PubMed ID: 11847474
[TBL] [Abstract][Full Text] [Related]
17. Clinical utility of measurements of insulin-like growth factor 1.
Clemmons DR
Nat Clin Pract Endocrinol Metab; 2006 Aug; 2(8):436-46. PubMed ID: 16932333
[TBL] [Abstract][Full Text] [Related]
18. Regulation of human growth hormone secretion and its disorders.
Kato Y; Murakami Y; Sohmiya M; Nishiki M
Intern Med; 2002 Jan; 41(1):7-13. PubMed ID: 11838603
[TBL] [Abstract][Full Text] [Related]
19. The relationship between 24-hour growth hormone secretion and insulin-like growth factor I in patients with successfully treated acromegaly: impact of surgery or radiotherapy.
Peacey SR; Toogood AA; Veldhuis JD; Thorner MO; Shalet SM
J Clin Endocrinol Metab; 2001 Jan; 86(1):259-66. PubMed ID: 11232010
[TBL] [Abstract][Full Text] [Related]
20. Use of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in the diagnosis of acromegaly and growth hormone deficiency in adults.
Thissen JP; Ketelslegers JM; Maiter D
Growth Regul; 1996 Dec; 6(4):222-9. PubMed ID: 8971551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
